Hyphens Pharma 4Q earnings grow 31.9% to $0.8 mil in absence of one-off IPO expenses

SINGAPORE (Mar 1): Hyphens Pharma International has announced earnings of $0.8 million for the 4Q ended Dec 2018, rising 31.9% from $0.6 million in 4Q17 in the absence of one-off IPO expenses incurred from the year before.

Excluding the impact of these one-off expenses, the group’s earnings would have increased 33% to $1.2 million from $0.9 million a year ago.